Exercise program study to boost vaccine immune response
Part of Immune system & allergy clinical trials.
This study looks at whether regular light-to-moderate exercise around the time of getting an mRNA COVID-19 vaccine can improve your immune response. It may help researchers understand how stress and exercise affect how well vaccines work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able to donate a small amount of blood for testing
- Plan to start an mRNA COVID-19 vaccine (first dose)
- Be 18 to 64 years old
- Exercise regularly (at least 2 days per week, with one session 50+ minutes, or 3+ walks per week with one 50+ minutes)
- Be able to safely do about 90 minutes of light-to-moderate exercise (walking or jogging)
- Not be pregnant, and weigh at least 110 pounds
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how your immune system responds after a COVID-19 vaccine. It uses detailed blood tests to understand what changes happen in your immune cells and may help researchers improve future vaccines.
This study looks at how different types of exercise—aerobic (like running) and resistance (like weightlifting)—change how your immune system works. Researchers will track your immune health over time to understand which exercise style might boost immunity best.
This study looks at how a single exercise session affects the heart and blood vessels in people with lasting COVID-19 symptoms. It may help understand if exercise is safe and helpful for recovery.
This study tests if a moderate exercise program can help people with certain antibody deficiencies. It aims to see if exercise improves immune function in people who are not taking immunoglobulin therapy.
This study tests whether a personalized exercise program can help reduce fatigue after a COVID-19 infection. You'll work with a coach over video calls to see if gentle activity can improve your energy levels.
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
Hear when a new Immunization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.